TriSalus Life Sciences, Inc. (TLSI) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 24 transactions totaling $100.3K, demonstrating a bullish sentiment with $100.2K in net insider flow. The most recent transaction on Feb 4, 2026 involved a transaction of 92,537 shares valued at $0.
No significant insider buying has been recorded for TLSI in the recent period.
No significant insider selling has been recorded for TLSI in the recent period.
Based on recent SEC filings, insider sentiment for TLSI is bullish with an Insider Alignment Score of 100/100 and a net flow of $100.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at TriSalus Life Sciences, Inc. (TLSI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading TLSI stock, having executed 24 transactions in the past 90 days. The most active insider is Mary T. Szela (Executive), who has made 8 transactions totaling $100.2K.
Get notified when executives and directors at TLSI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | P. Stansky Michael | Executive | Award | 92,537 | $N/A | $0 | |
| Nov 24, 2025 | Patience David | Executive | Award | 65,000 | $N/A | $0 | |
| Nov 24, 2025 | Marshak Richard | Executive | Award | 60,000 | $N/A | $0 | |
| Nov 24, 2025 | Stevens Jennifer | Executive | Award | 50,000 | $N/A | $0 | |
| Nov 24, 2025 | T. Szela Mary | Executive | Award | 125,000 | $N/A | $0 | |
| Nov 24, 2025 | T. Szela Mary | Executive | Award | 300,000 | $N/A | $0 | |
| Nov 24, 2025 | Devlin Jodi | Executive | Award | 50,000 | $N/A | $0 | |
| Nov 24, 2025 | F. Cox Bryan | Executive | Award | 40,000 | $N/A | $0 | |
| Aug 14, 2025 | Patience David | Executive | Award | 200,000 | $N/A | $0 | |
| Sep 13, 2024 | T. Szela Mary | Executive | Purchase | 6,000 | $5.00 | $30.0K | |
| Sep 13, 2024 | T. Szela Mary | Executive | Purchase | 1,295 | $4.83 | $6.3K | |
| Sep 12, 2024 | T. Szela Mary | Executive | Purchase | 7,520 | $5.20 | $39.1K | |
| Sep 10, 2024 | T. Szela Mary | Executive | Purchase | 5,000 | $4.97 | $24.9K | |
| Aug 28, 2024 | Kelly Martin George | Executive | Sale | 9 | $5.50 | $50 | |
| Jul 1, 2024 | Jj Desai Arjun | Executive | Award | 74,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 4 | $100.2K | 100.0% |
Sale(S) | 1 | $50 | 0.0% |
Award(A) | 18 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at TriSalus Life Sciences, Inc. are accumulating shares at an accelerated pace. With 12 insiders making 24 transactions totaling $100.2K in purchases versus $50 in sales, the net buying activity of $100.2K signals strong executive confidence. Mary T. Szela (Executive) leads the buying activity with $100.2K in transactions across all time.